BCL11A and breast carcinoma: These findings suggest BCL11A is a new potential diagnostic biomarker and therapeutic target for TNBC; yet, whether BCL11A can be used for breast cancer diagnosis or drug development is still a challenge since the molecular mechanism of BCL11A in TNBC is unclear.